Silverfin false false 31/07/2023 31/07/2023 01/08/2022 The principal activity of the Company during the financial year was that of specialist medical activities. Dr Alexandra Creavin 01/12/2018 Dr Samuel Thomas Creavin 30/07/2015 09711452 2023-07-31 09711452 bus:Director1 2023-07-31 09711452 bus:Director2 2023-07-31 09711452 2022-07-31 09711452 core:CurrentFinancialInstruments 2023-07-31 09711452 core:CurrentFinancialInstruments 2022-07-31 09711452 2022-08-01 2023-07-31 09711452 bus:Micro-entities 2022-08-01 2023-07-31 09711452 bus:FilletedAccounts 2022-08-01 2023-07-31 09711452 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 09711452 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 09711452 bus:Director1 2022-08-01 2023-07-31 09711452 bus:Director2 2022-08-01 2023-07-31 09711452 2021-08-01 2022-07-31 iso4217:GBP xbrli:pure

Company No: 09711452 (England and Wales)

PUFFIN MEDICAL INVESTMENTS LTD

Unaudited Financial Statements
For the financial year ended 31 July 2023
Pages for filing with the registrar

PUFFIN MEDICAL INVESTMENTS LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 July 2023

Contents

PUFFIN MEDICAL INVESTMENTS LTD

BALANCE SHEET

As at 31 July 2023
PUFFIN MEDICAL INVESTMENTS LTD

BALANCE SHEET (continued)

For the financial year ended 31 July 2023
2023 2022
£ £
Fixed assets - 59
Current assets 23,363 18,989
Creditors: amounts falling due within one year ( 6,173) ( 4,903)
Net current assets 17,190 14,086
Total assets less current liabilities 17,190 14,145
Accruals and deferred income ( 1,350) ( 1,285)
Net assets 15,840 12,860
Capital and reserves 15,840 12,860

For the financial year ending 31 July 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Puffin Medical Investments Ltd (registered number: 09711452) were approved and authorised for issue by the Board of Directors on 05 April 2024 and were signed on its behalf by:

Dr Samuel Thomas Creavin
Director
PUFFIN MEDICAL INVESTMENTS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 July 2023
PUFFIN MEDICAL INVESTMENTS LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 July 2023

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 09711452). The address of its registered office is 5th Floor, 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 3 3